First UK Gene Therapy Trial Significantly Slows Huntington's Disease Progression
TL;DR Summary
Researchers in the UK have trialed a promising gene therapy, AMT-130, which can slow Huntington's disease progression by up to 75% over three years, potentially offering the first effective treatment for this fatal neurodegenerative disorder.
- Breakthrough Gene Therapy Slows Huntington's Disease by 75% ScienceAlert
- First successful Huntington’s treatment slows disease progression in small study The Washington Post
- Huntington's breakthrough 'amazing' but with 'caveats' BBC
- A clever genetic technique may treat a horrible brain condition The Economist
- Huntington’s disease treated successfully for first time in UK gene therapy trial The Guardian
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
95%
662 → 35 words
Want the full story? Read the original article
Read on ScienceAlert